Kevin X. Chen
University of California, San Francisco(US)WuXi AppTec (China)(CN)Broad Center(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Cancer therapeutics and mechanisms, Hepatitis B Virus Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2008)261 cited
- → GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)(2017)126 cited
- → Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor(2010)97 cited
- → Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300(2016)94 cited
- A review of HCV protease inhibitors.(2009)
- → Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease(2008)52 cited
- → I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles